Ogletree ML - Search Results

1

Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.

Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML. Schumacher WA, et al. Among authors: ogletree ml. J Pharmacol Exp Ther. 1993 Dec;267(3):1237-42. J Pharmacol Exp Ther. 1993. PMID: 8263785

2

Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.

Das J, Kimball SD, Reid JA, Wang TC, Lau WF, Roberts DG, Seiler SM, Schumacher WA, Ogletree ML. Das J, et al. Among authors: ogletree ml. Bioorg Med Chem Lett. 2002 Jan 7;12(1):41-4. doi: 10.1016/s0960-894x(01)00664-3. Bioorg Med Chem Lett. 2002. PMID: 11738569

3

Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.

Iwanowicz EJ, Kimball SD, Lin J, Lau W, Han WC, Wang TC, Roberts DG, Schumacher WA, Ogletree ML, Seiler SM. Iwanowicz EJ, et al. Among authors: ogletree ml. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3183-6. doi: 10.1016/s0960-894x(02)00651-0. Bioorg Med Chem Lett. 2002. PMID: 12372529

4

Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in rats.

Schumacher WA, Bostwick JS, Ogletree ML, Stewart AB, Steinbacher TE, Hua J, Price LA, Wong PC, Rehfuss RP. Schumacher WA, et al. Among authors: ogletree ml. J Pharmacol Exp Ther. 2007 Jul;322(1):369-77. doi: 10.1124/jpet.106.119156. Epub 2007 Apr 9. J Pharmacol Exp Ther. 2007. PMID: 17420297

5

Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.

Schumacher WA, Heran CL, Hartl KS, Ogletree ML. Schumacher WA, et al. Among authors: ogletree ml. J Pharmacol Exp Ther. 1990 May;253(2):841-6. J Pharmacol Exp Ther. 1990. PMID: 2140131

6

Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.

Schumacher WA, Goldenberg HJ, Harris DN, Ogletree ML. Schumacher WA, et al. Among authors: ogletree ml. J Pharmacol Exp Ther. 1987 Nov;243(2):460-6. J Pharmacol Exp Ther. 1987. PMID: 2960794

7

Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis.

Schumacher WA, Heran CL, Steinbacher TE, Youssef S, Ogletree ML. Schumacher WA, et al. Among authors: ogletree ml. J Cardiovasc Pharmacol. 1993 Oct;22(4):526-33. doi: 10.1097/00005344-199310000-00004. J Cardiovasc Pharmacol. 1993. PMID: 7505353

8

Thromboxane receptor antagonist BMS-180291, but not aspirin, reduces the severity of pacing-induced ischemia in dogs.

Grover GJ, Schumacher WA, Ogletree ML. Grover GJ, et al. Among authors: ogletree ml. J Cardiovasc Pharmacol. 1994 Sep;24(3):493-9. doi: 10.1097/00005344-199409000-00019. J Cardiovasc Pharmacol. 1994. PMID: 7528306

9

Gomoll AW, Schumacher WA, Ogletree ML. Gomoll AW, et al. Among authors: ogletree ml. Pharmacology. 1995 Feb;50(2):92-110. doi: 10.1159/000139271. Pharmacology. 1995. PMID: 7716179

10

Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN. Ogletree ML, et al. J Pharmacol Exp Ther. 1993 Feb;264(2):570-8. J Pharmacol Exp Ther. 1993. PMID: 8437108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters